Skip to main content
. Author manuscript; available in PMC: 2008 Sep 1.
Published in final edited form as: Gen Hosp Psychiatry. 2007;29(5):396–401. doi: 10.1016/j.genhosppsych.2007.07.001

Table 2.

Univariate Predictors of Willingness to Taper/Discontinue Benzodiazepine Treatment

Variable Willing: M (SD) or % (N) Unwilling: M (SD) or % (N) Statistical test
Education
High School or less 13.0 47.8 χ2 = 4.07*
Above High School 19.6 19.6 Lχ2 = 4.04*
Frequency
Less than one daily 15.2 8.7 U = 131.00*
One daily 6.5 19.6
Up to two daily 8.7 15.2
Three to five daily 2.2 23.9
ASI 9.3 (6.4) 15.4 ((10.8) t = 2.43* (42.06)
BAI 4.5 (4.8) 10.1 (9.9) t = 2.60* (43.98)
CESD 10.6 (9.7) 13.5 (11.1) t = .86 (44)
PSQI 6.2 (3.9) 6.9 (3.7) t = .59 (44)
SDS 5.6 (1.8) 5.5 (2.5) t = -.10 (44)

Note. Willingness = willingness to attempt taper/discontinue benzodiazepine treatment; Education = level of education; Frequency = frequency of daily benzodiazepine intake; ASI = Anxiety Sensitivity Index; BAI = Beck Anxiety Inventory; CESD = The Center for Epidemiological Studies Depression Scale; PSQI = Pittsburgh Sleep Quality Index; SDS = Severity of Dependence Scale.

*

p < .05.